How COVID-19 Has Impacted one Non-Profit's Fundraising Efforts for Breast Reconstruction Surgery After Cancer

Video

Although one non-profit has decided to place fundraising efforts on the back burner since the start of COVID-19, one of the organization’s founding members notes it is still sticking to its mission.

As the new coronavirus has spread across the United States, unemployment rates have reached levels not seen since the Great Depression. As a result, millions of residents have filed for unemployment benefits.

In a recent interview with CURE®, Morgan Hare, a founding member of the AiRS Foundation, discussed how the organization has decided to put fundraising efforts on the back burner since the start of COVID-19.

Additionally, Hare discussed how the organization, which helps educate women with breast cancer about their reconstruction options and meet their co-pays or pay for their surgery, has received fewer calls from applicants recently.

Hare stressed, however, that the organization is still sticking to its mission, even if it is not actively fundraising at this time.

Transcript:

That's a problem. It's very hard during this time period to go out and fund-raise. I think people are very worried about how much they have lost in the stock market, and what's going to happen, are they going to be employed, not be employed. We have sort of at this moment backed off from doing fundraising if someone wants to make a donation, trust me we would like it, but we understand that this is a difficult time. So, we have sort of put fundraising a little bit on the backburner but again anyone who wants to make a donation we would be really happy to receive donations at this point.

Luckily, we have no backlog, we have continued to support this in any way because we don't want anyone who is ready not to have the surgery. So, between my business partner, Janet Denlinger, and Dr. Rohrich, we will continue to fund this to make sure no one goes without their surgery during this time.

It has dipped. I would say I was getting four or five calls a week, and maybe last week I had two. So, I would say that people are not focusing on this quite as much as they had been. Probably because their doctors are telling them that their reconstructive surgery is being put on hold. But the ones that were in the cue, we're still funding and moving those along so anyone who is doing surgery, we're making sure that that happens. But most of the plastic surgeons are not doing anything that is considered not essential surgeries.

Related Videos
Image of a woman with short blonde hair wearing a white blazer.
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Image of a woman with black hair.
Image of a woman with brown shoulder-length hair in front of a gray background that says CURE.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Related Content